AstraZeneca and Eli Lilly have joined the ranks of drugmakers around the world trying to repurpose existing drugs for use in severely-ill COVID-19 patients as the number of cases worldwide approaches 2 million.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,